Absence
epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2.
Embo J 22(2), 216-224.
Mistrik, P., Mader, R., Michalakis, S., Weidinger, M., Pfeifer, A., and Biel, M.
(2005) The
OD260/280 ratio too high
(> 1.9)
RNA contamination RNase treatment insufficient, increase time up to
1 hour.
Sheared DNA Do not vortex sample unless stated in procedure.
OD260/280 ratio too
0,1 g 280 x 356 mm 10 kg, F1 80108961 2000
EP12001C 12000 g 0,1 g 280 x 356 mm 10 kg, F1 80108960 2230
EP12001CM 12000 g 0,1 g 1 g 280 x 356 mm 10 kg, F1 80108963 2360
EP22001 22000
., et al. 1998. FEBS Lett. 436, 367; Angliker, H., et al. 1992. J. Med. Chem.
35, 216.
Calpain Inhibitor VI [N-(4-Fluorophenylsulfonyl)-L-
valyl-L-leucinal]
A potent, cell-permeable, reversible inhibitor
group Open user&group setting window 215 NO NO NO NO NO YES
Backup&Restore 216-Backup&Restore Save, delete, restore back-up 216 NO NO NO NO NO YES
AI scale&filter 217-AI scale&filter Scale & filter analog
Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5
Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5
in stress
and inflammatory responses, nuclear export, and cell
proliferation. Specific activity: ≥216 nmol/min/mg protein.
Purity: ≥90% by SDS-PAGE.
Cat. No. 475861 5 mg € 139
Ref.: McCormick, C .
Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5
D2178 M y n/d n/d
214 phospho-DAPK (pSer308) D4941 M y n/d n/d
215 DAP Kinase 2 D3191 P y y y
216 Anti Cy3+Cy5 C0992 M NA NA NA
217 Daxx D7810 P y n/d n/d
218 DcR1 D3566 P y y y
219